The Valley Desk

NCT00110617 · Interventional trial

Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients

Overall registry status Completed

Phase 2

Conditions Hemolytic Anemia, Iron Overload, Sickle Cell Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov